Human papillomavirus vaccine: progress and the future

By Dinh Tri A   Benoit Michelle F  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 479-485

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

By Hung Chien-Fu   Ma Barbara   Monie Archana   Tsen Shaw-Wei   Wu T-C  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 421-439

Informa Healthcare

Access to resources Recommend Favorite

Pre-clinical pharmacokinetics of the acridine antitumour candidate AC04 and its 1-oxo-metabolite plasma profile

By Pigatto Maiara Cássia   Uchôa Flávia De Toni   Torres Bruna   Haas Sandra   do Carmo Alves de Lima Maria   Galdino Suely Lins   Rocha Pitta Ivan da   Peporine Lopes Norberto   Dalla Costa Teresa  

Xenobiotica, Vol. 42, Iss. 7, 2012-07 ,pp. : 701-707

Informa Healthcare

Access to resources Recommend Favorite

Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer

By Crosbie Emma J   Kitchener Henry C  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite

Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases

By Blencowe B.J.B.J.  

Trends in Biochemical Sciences, Vol. 25, Iss. 3, 2000-03 ,pp. : 106-110

Elsevier

Access to resources Recommend Favorite